Risk of target organ damage in patients with arterial hypertension and various numbers of metabolic syndrome components
Zhernakova Y.V., Sharipova G.K., Chazova I.E.
Hyperfiltration and metabolic syndrome
Arutyunov G.P., Oganezova L.G., Arutyunov G.P., Oganezova L.G.
Nephroprotective in patients with metabolic syndrome: approaches to the appointment of antihypertensive drugs
Ostroumova O.D., Zykova A.A., Maksimov M.L.
The treatment options of the new angiotensin II receptor blocker - azilsartan medoxomil in the therapy of hypertension in patients with metabolic disorders
Zhernakov Y.V., Chazova I.Y.
Possible combinations of antihypertensive drugs at treatment of arterial hypertension at patientswith metabolic syndrome
Mychka V.B., Chazova I.E., Mychka V.B., Chazova I.E.
Recommendations on treatment strategies in hypertensivepatientswithmetabolic disorders
Zhernakova Y.V., Chazova I.E.
Assessment of epicardial adipose tissue by echocardiography for risk stratification in young adults with abdominal obesity
Blinova N.V., Azimova M.O., Zhernakova J.V., Saidova M.A., Ternovoy S.K., Zheleznova E.A., Azimova M.R., Chazova I.Е.
Metabolic syndrome
Mychka V.B., Chazova I.E., Mychka V.B., Chazova I.E.
Efficacy and safety of using a fixed-dose combination of azilsartan medoxomil and chlorthalidone in patients with diabetes mellitus
Zhernakova J.V., Chazova I.E.
Communication of subcutaneous, visceral, periaortic, epicardial fat and metabolic parameters with arterial stiffness in young people with abdominal obesity
Zheleznova E.A., Zhernakova Y.V., Chazova I.E., Rogoza A.N., Zairova A.R., Shariya M.A., Yarovaya E.B., Orlovsky A.A., Blinova N.V., Azimova M.O., Gorieva S.B., Konosova I.D.
The possibility of perindopril in angioprotective in patients with metabolic syndrome after combination therapy with a thiazide diuretic
Nedogoda S.V., Smirnova V.O., Khripaeva V.Y., Palashkin R.V., Ledyaeva A.A., Chumachok E.V., Salasyuk A.S.
Hypertension treatment features in perimenopausal women
Zhernakova Y.V., Chazova I.E.
Impact of metabolic syndrome parameters and different fat depots on arterial stiffness in patients with abdominal obesity
Andreevskaia M.V., Zheleznova E.A., Zhernakova J.V., Chazova I.E., Shariia M.A., Blinova N.V., Zairova A.R., Azimova M.O., Rogoza A.N., Saidova M.A.
The new angiotensin II receptor blocker Edarbi® as part of the pathogenetic treatment of arterial hypertension in patients with metabolic disorders
Chazova I.Y., Zhernakova Y.V., Blinova N.V., Rogoza A.N.
Patients with arterial hypertension associated with metabolic disorders: characteristics and therapeutic approach
Zhernakova Y.V., Sharipova G.H., Chazova I.E.
Efficacy of irbesartan in arterial hypertension and metabolic syndrome
Ostroumova O.D., Zykova A.A., Polosova T.A., Bondarets O.V.
Effects of amlodipine and atorvastatin on endothelial vasoactive mediators in patients with metabolic syndrome
Blinova N.V., Masenko V.P., Chazova I.E.
Additional possibilities of antihypertensive therapy for metabolic syndrome
Kislyak O.A., Pokhilchenko M.V.
Vascular wall status and its link with perivascular adipose tissue and other fat depots in young patients with abdominal obesity
Zheleznova E.A., Zhernakova J.V., Pogorelova O.A., Tripoten M.I., Blinova N.V., Shariya M.A., Azimova M.O., Gorieva S.B., Maslov A.V., Balakhonova T.V., Chazova I.E.
Fixed combination of highly selective β-adrenoblocker bisoprolol and calcium antagonist amlodipine (Concor® AM) for arterial hypertension treatment in metabolic disorder patients
Zhernakova Y.V., Martyniuk T.V., Arkhipova O.A., Azimova M.O., Rogoza A.N., Chazova I.E.
Influence of metabolic syndrome components on the level of nitric oxide stable metabolites in patients with essential hypertension
Podzolkov V.I., Bragina A.E., Bragina G.I., Murashko N.A.
Use of diuretics in hypertensive patients with metabolic disturbances
Zhernakova Y.V., Chazova I.E.
The possibilities of angiotensin receptor blocker azilsartan medoxomil and its combination with chlortalidone in cardiovascular risk decrease in patients with obesity, metabolic syndrome and diabetes mellitus
Zhernakova J.V., Chazova I.E., Blinova N.V.
The patients of high cardiovascular risk of healthy: unrecognized metabolic syndrome
Blinova N.V., Zhernakova Y.V., Chazova I.E., Oshchepkova E.V.
Effect of angiotensin II receptor antagonists on left ventricular hypertrophy, vascular elasticity, and lipid and carbohydrate metabolic parameters in metabolic syndrome
Nedogoda S.V., Salasyuk A.S., Chalyabi T.A., Barykina I.N., Pocheptsov D.A., Ledyaeva A.A., Tsoma V.V., Chumachek E.V.
1 - 25 of 25 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies